Introduction
============

In the eukaryotic nucleus, genomic DNA is packaged into chromatin by forming nucleosomes. Each nucleosome core particle consists of a histone octamer which is wrapped by 146 base pairs of DNA (Luger et al., [@B49]). A histone octamer is composed of two copies of the core histones H2A, H2B, H3, and H4. The histone tails protrude from the nucleosome, and are subjected to a wide array of covalent modifications include methylation, acetylation, ubiquitination, phosphorylation, sumoylation, and ADP ribosylation (Strahl and Allis, [@B80]). These post-transcriptional modifications work together to regulate the chromatin structure, which affects biological processes including gene expression, DNA repair, and chromosome condensation. Recent advances have defined critical roles of histone ubiquitination in transcriptional regulation and DNA repair. The writers, erasers, and readers of histone ubiquitination have also been linked to cancer development.

Histone Ubiquitination
======================

Histone H2A is the first protein identified to be modified by ubiquitin in cells (Goldknopf et al., [@B22]). We know now H2A and H2B are two of the most abundant ubiquitinated proteins in the nucleus. It is estimated that 5--15% of H2A and 1--2% of H2B are conjugated with ubiquitin in vertebrate cells, while about 10% of H2B are ubiquitinated in yeast cells (Goldknopf et al., [@B22]; Matsui et al., [@B55]; West and Bonner, [@B88]; Robzyk et al., [@B69]).

The dominant form of ubiquitinated histones are monoubiquitinated H2A (H2Aub) and H2B (H2Bub). A single molecule of ubiquitin is added to the highly conserved lysine residues: Lys-119 for H2A, and Lys-123 in yeast or Lys-120 in vertebrate for H2B (Figure [1](#F1){ref-type="fig"}; Goldknopf et al., [@B22]; West and Bonner, [@B88]). Chromatin immunoprecipitation (ChIP) experiments showed that monoubiquitinated H2A is enriched in the satellite regions of genome, while H2Bub binds to the gene body of transcriptional active genes (Minsky et al., [@B56]; Shema et al., [@B75]; Zhu et al., [@B106]).

![**Ubiquitin ligases and deubiquitinating enzymes responsible for monoubiquitination of histones H2A and H2B**. Major post-transcriptional modifications on histone H3 and H4 tails are also shown. Ac, acetylation; Me, methylation; P, phosphorylation.](fonc-02-00026-g001){#F1}

In addition to H2A and H2B, core histones H3, H4, and linker histone H1 have also been reported to be modified by ubiquitin (Pham and Sauer, [@B66]; Jason et al., [@B28]; Wang et al., [@B87]; Jones et al., [@B29]). For example, H3 and H4 were polyubiquitinated *in vivo* by CUL4--DDB--RBX1 ubiquitin ligase complex after UV irradiation (Wang et al., [@B87]). But the biological function of these modifications has not been well elucidated.

Besides monoubiquitination, histone H2A and H2B can be modified by ubiquitin chains. K63-linked polyubiquitination of H2A and H2AX, a variant of H2A, is usually induced by DNA damage and is required for DNA repair response (Huen et al., [@B26]; Kolas et al., [@B40]; Mailand et al., [@B52]; Wang and Elledge, [@B84]; Doil et al., [@B11]; Stewart et al., [@B77]). Like other proteins, formation of K48-linked ubiquitin chains on histones targets them for proteasome mediated degradation. For example, during spermatogenesis, histones are degraded through this mechanism and replaced by transition proteins to permit chromatin condensation (Chen et al., [@B8]; Liu et al., [@B48]).

Histone Ubiquitination Enzymes
==============================

In this section, we will summarize our current knowledge on the histone modifying enzymes that can add ubiquitin to or remove it from histones (Figure [1](#F1){ref-type="fig"}; Table [1](#T1){ref-type="table"}).

###### 

**Functions of histone modifying enzymes for monoubiquitination**.

  Enzyme               Species              Histone specificity   Enzymatic activity   Role in transcription   Reference
  -------------------- -------------------- --------------------- -------------------- ----------------------- -----------------------------------------------
  RING1A/RING1B/BMI1   Human                H2A                   E3                   Repression              Cao et al. ([@B5]); Gearhart et al. ([@B18])
  2A-HUB               Human                H2A                   E3                   Repression              Zhou et al. ([@B103])
  BRCA1/BARD1          Human                H2A                   E3                   Repression              Chen et al. ([@B7]); Zhu et al. ([@B106])
  UbcH5c               Human                H2A                   E2                   N/A                     Chen et al. ([@B7])
  Bre1                 Yeast                H2B                   E3                   Activation              Robzyk et al. ([@B69]); Kao et al. ([@B34])
  Rad6                 Yeast                H2B                   E2                   Activation              Robzyk et al. ([@B69]); Kao et al. ([@B34])
  RNF20/40             Human                H2B                   E3                   Activation              Kim et al. ([@B37]); Prenzel et al. ([@B67])
  RAD6A/B              Human                H2B                   E2                   Activation              Kim et al. ([@B37])
  UbcH6                Human                H2B                   E2                   Activation              Zhu et al. ([@B104])
  USP16                Human                H2A                   DUB                  Activation              Joo et al. ([@B32]); Shanbhag et al. ([@B72])
  USP21                Human                H2A                   DUB                  Activation              Nakagawa et al. ([@B59])
  2A-DUB               Human                H2A                   DUB                  Activation              Zhu et al. ([@B105])
  BAP1                 Human *Drosophila*   H2A                   DUB                  Activation              Scheuermann et al. ([@B70])
  Ubp8                 Yeast                H2B                   DUB                  Activation              Henry et al. ([@B24]); Daniel et al. ([@B9])
  Ubp10                Yeast                H2B                   DUB                  Repression              Emre et al. ([@B13])
  Ubp7                 *Drosophila*         H2B                   DUB                  Repression              van der Knaap et al. ([@B83])
  SCNY                 *Drosophila*         H2B                   DUB                  Repression              Buszczak et al. ([@B4])
  UBP12/46             *Xenopus*            H2A H2B               DUB                  Activation              Joo et al. ([@B31])
  USP3                 Human                H2A H2B               DUB                  N/A                     Nicassio et al. ([@B61])
  USP22                Human                H2A H2B               DUB                  Activation              Zhang et al. ([@B100]); Zhao et al. ([@B102])

Histone ubiquitin ligases
-------------------------

Polycomb group protein RING1B is the first identified ubiquitin ligase (E3) responsible for monoubiquitination of H2A at lysine 119 (Wang et al., [@B86]; Cao et al., [@B5]). Loss of RING1B dramatically decreases H2A monoubiquitination globally and at the promoters of specific genes (Wang et al., [@B86]; Cao et al., [@B5]). Two other RING domain containing proteins in the PRC1 (Polycomb Repressive Complex 1) complex, RING1A, and BMI1, strongly stimulate the E3 ubiquitin ligase activity of RING1B (Cao et al., [@B5]; Buchwald et al., [@B3]). Another H2A-specific E3, 2A-HUB/hRUL138 is recruited by the NCoR/HDAC1/3 complex and catalyzes H2A monoubiquitination at Lysine 119 (Zhou et al., [@B103]). Breast cancer type 1 susceptibility gene (BRCA1) is also a potential E3 ubiquitin ligase for histone H2A. In an *in vitro* ubiquitination assay, BRCA1 cooperates with ubiquitin-conjugating enzyme (E2) UbcH5c to catalyze monoubiquitination of H2A/H2AX (Chen et al., [@B7]). In an *in vivo* study, BRCA1 co-localizes with H2Aub on satellite DNA, and loss of BRCA1 results in the decrease of H2Aub occupation in these regions (Zhu et al., [@B106]). Another RING finger containing protein BARD1, which carries an enzyme dead mutation in its RING finger, binds to BRCA1 and enhances its E3 activity (Xia et al., [@B95]). Although several ubiquitin ligases can catalyze H2A monoubiquitination, loss of RING1A, RING1B, or BMI1 leads to global decrease of H2Aub, suggesting the RING1A/RING1B/BMI1 complex is the major E3 in mammalian cells (de Napoles et al., [@B10]; Wang et al., [@B86]; Cao et al., [@B5]; Stock et al., [@B79]).

The enzymes responsible for H2B monoubiquitination were first identified in yeast: Rad6 as a ubiquitin-conjugating enzyme and Bre1 as a ubiquitin ligase (Robzyk et al., [@B69]; Hwang et al., [@B27]; Wood et al., [@B91]; Kao et al., [@B34]). There are two homologs of Bre1 in mammalian cells: RNF20 and RNF40 (Koken et al., [@B39]; Kim et al., [@B37]). RNF20 and RNF40 form a complex *in vivo*, associate with yRad6 homologs hRAD6A and hRAD6B, or another ubiquitin-conjugating enzyme UbcH6, and catalyze monoubiquitination of H2B at lysine 120 *in vitro* (Kim et al., [@B37], [@B36]; Zhu et al., [@B104]). Knockdown of RNF20 or RNF40 significantly reduces H2Bub globally in human cells (Kim et al., [@B37]; Zhu et al., [@B104]). The SWI/SNF-A subunit BAF250b associates with Elongin B and C, CUL2, and RBX1 to form a canonical Elongin BC containing ubiquitin ligase complex similar to the VHL or E4orf6 complex (Kamura et al., [@B33]; Querido et al., [@B68]; Yan et al., [@B98]). This BAF250b complex can also catalyze H2B monoubiquitination (Li et al., [@B46]).

Histones H2A and H2AX can also be polyubiquitinated by a related ubiquitin ligase complex. RNF8 and RNF168 catalyze formation of K63-linked polyubiquitination chain in histones H2A and H2AX at the site of DNA damage during DNA damage repair (Stewart et al., [@B77]). Polyubiquitination of H2A and H2AX facilitates the accumulation of DNA repair proteins including 53BP1 and BRCA1 at the DNA damage foci (Huen et al., [@B26]; Kolas et al., [@B40]; Mailand et al., [@B52]; Wang and Elledge, [@B84]; Doil et al., [@B11]; Stewart et al., [@B77]).

Histone deubiquitinating enzymes
--------------------------------

Like other histone modifications, monoubiquitination of histones H2A and H2B is reversible. The ubiquitin modification can be removed by ubiquitin specific peptidases known as deubiquitinating enzymes (DUBs).

Several DUBs, including USP16, 2A-DUB, USP21, and BRCA1 associated protein 1 (BAP1) were identified as H2A-specific. USP16 catalyzes H2A deubiquitination *in vitro* and *in vivo*, and plays important roles in H2Aub mediated *HOX* gene silencing, X chromosome inactivation, cell cycle progression, and DNA damage repair (Joo et al., [@B32]; Shanbhag et al., [@B72]). 2A-DUB interacts with PCAF and is required for full activation of androgen receptor-dependent genes (Zhu et al., [@B105]). Another H2A-specific DUB, USP21, was identified as a regulator of liver regeneration by deubiquitination of H2Aub at the promoters of regeneration related genes (Nakagawa et al., [@B59]). The polycomb protein BAP1, was identified as an H2A-specific histone C-terminal hydrolase. BAP1 removes monoubiquitin from H2A but not H2B *in vivo* and *in vitro*. Loss of BAP1 significantly increases H2Aub level and abolishes the repression of *HOX* genes in flies (Scheuermann et al., [@B70]).

Ubp8 and Ubp10 were identified as histone H2B DUBs in yeast (Henry et al., [@B24]; Daniel et al., [@B9]; Emre et al., [@B13]), but they have very different functions. Ubp8 co-localizes with H3K4me3, while Ubp10 binds to H3K79me3 enriched sites, as well as telomere and rDNA locus (Emre et al., [@B13]; Schulze et al., [@B71]). Ubp8 catalyzes H2B deubiquitination *in vitro* and loss of Ubp8 increases the global level of H2Bub (Henry et al., [@B24]; Daniel et al., [@B9]), suggesting that Ubp8 is the major H2Bub DUB in yeast. Furthermore, as a component of the SAGA acetylation complex, Ubp8 is required for the transcription of SAGA-regulated genes (Henry et al., [@B24]). In addition, USP7 has been shown to catalyze H2B deubiquitination and mediate epigenetic silencing of homeotic genes (van der Knaap et al., [@B83]). *Drosophila* ubiquitin protease SCNY, a homolog of yeast Ubp10, deubiquitinates monoubiquitinated H2B *in vitro* (Buszczak et al., [@B4]). Loss of SCNY increases monoubiquitinated H2B in larvae (Buszczak et al., [@B4]). Interestingly, SCNY is required for maintaining multiple types of adult stem cells (Buszczak et al., [@B4]).

In addition to H2A or H2B specific DUBs, several DUBs display dual specificity toward both H2Aub and H2Bub, such as USP3, USP12, and USP46. USP3 is required for cell cycle progression and genome stability, while USP12 and USP46 regulate *Xenopus* development (Nicassio et al., [@B61]; Joo et al., [@B31]). The Ubp8 homolog USP22 is a subunit of coactivator acetyltransferase hSAGA complex. It is recruited to the promoters by activators to deubiquitinate H2A and H2B, and is required for transcription activation (Zhang et al., [@B100]; Zhao et al., [@B102]).

Multiple histone DUBs were identified, suggesting that they may have redundant functions or act in a context-dependent manner. Although their redundancy was not extensively investigated, current literature supports the notion that these DUBs have context-dependent functions in various processes. Their functions may also be dictated by their expression patterns in different tissues and stages during development.

Function of Histone Ubiquitination
==================================

As histones are the most abundant ubiquitinated proteins, their ubiquitination plays critical roles in many processes in the nucleus, including transcription, maintenance of chromatin structure, and DNA repair.

Transcription
-------------

Monoubiquitination of H2A and H2B have been clearly implicated in transcriptional regulation. H2Aub occupation is more frequently correlated with gene silencing, while H2Bub is mostly associated with transcription activation.

H2A ubiquitin ligases were found in transcription repressor complexes, such as the PRC1, BCoR, E2F6.com-1, and 2A-HUB complexes (Ogawa et al., [@B62]; Wang et al., [@B86]; Cao et al., [@B5]; Gearhart et al., [@B18]; Zhou et al., [@B103]). RING1B mediated H2Aub is required for polycomb targeted gene silencing (Cao et al., [@B5]). Furthermore, in an *in vitro* assay, H2Aub represses transcriptional initiation and inhibits the formation of transcriptional active markers H3K4me2 and me3 (Nakagawa et al., [@B59]). The fact that H2A DUBs are usually required for genes activation (Joo et al., [@B32]; Zhu et al., [@B105]; Zhao et al., [@B102]) provides a second line of evidence for the gene silencing function of H2Aub.

In contrast, H2Bub occupation is strongly correlated with active gene expression in most cases, likely through multiple mechanisms, including promoting other active histone modifications and Pol II elongation. In a ChIP-on-Chip experiment, H2B monoubiquitination was found in the transcribed regions of highly expressed genes (Minsky et al., [@B56]). In yeast, monoubiquitinated H2B is required for the COMPASS complex for di- and tri-methylation of H3 at lysine 4 (Dover et al., [@B12]; Sun and Allis, [@B81]; Lee et al., [@B43]), which are active markers for transcription (Klose et al., [@B38]; Blair et al., [@B2]). Loss of E2, E3, or the ubiquitination site (K123) within H2B inhibits H3K4 methylation by the COMPASS complex (Sun and Allis, [@B81]; Wood et al., [@B91]). In mammalian cells, E2 UbcH6 and E3 complex RNF20/RNF40 are recruited to transcriptionally active genes (Zhu et al., [@B104]). RNF20 also binds to transcription factors such as p53 directly and functions as a coactivator (Kim et al., [@B37]). Overexpression of RNF20 leads to elevated H2B monoubiquitination globally, which leads to subsequent increase of methylation at lysine 4 and 79 in H3, and stimulation of *HOX* gene expression (Zhu et al., [@B104]). Conversely, knockdown of RNF20 decreases endogenous H2Bub, H3K4, and K79 methylation, and therefore transcription (Kim et al., [@B37]). Moreover, transcriptional regulation by RNF20 is dependent on its E3 ligase activity (Shema et al., [@B74]).

Recent work implicated the function of H2Bub in regulating transcriptional elongation, suggesting that it is also a mechanism by which H2Bub plays a positive role in gene expression. H2B ubiquitination is associated with elongating RNA Polymerase II, and is necessary for reassembly of nucleosomes and restoration of the chromatin structure during the transcription elongation, thus influencing the kinetic properties of elongating Pol II (Xiao et al., [@B96]). Using a reconstituted chromatin transcription system, Reinberg and colleagues showed that H2Bub stimulates elongation by Pol II through the chromatin by promoting the replacement of H2A/H2B dimers from the core nucleosomes (Pavri et al., [@B65]). A recent study showed that monoubiquitinated H2B cooperates with acetylated H4 to disrupt chromatin compaction, which leads to an open and accessible chromatin structure (Fierz et al., [@B16]). Furthermore, yeast mutants carrying defects in H2B ubiquitination pathway display transcription elongation defects (Xiao et al., [@B96]).

However, H2B monoubiquitination may also repress gene expression in some cases. H2B DUBs, for example, were found in some coactivator complexes and they are required for coactivator-dependent gene activation in both yeast and mammalian cells (Henry et al., [@B24]; Zhang et al., [@B100]; Zhao et al., [@B102]). One of these DUBs, Ubp8, promotes Pol II CTD phosphorylation, which is a mark of transcription elongation and is required for co-transcriptional mRNA processing (Wyce et al., [@B94]). Both E3s and DUBs of H2Bub showed a positive effect on gene activation, suggesting the ubiquitination and deubiquitination cycle of H2B is required for full gene induction (Henry et al., [@B24]; Wyce et al., [@B94]).

Many studies demonstrated that histone ubiquitination and other histone modifications are inter-connected and they act in combination and/or sequentially to regulate transcription. For example, H2B monoubiquitination is required for both H3K4 methylation and H3K79 methylation (Dover et al., [@B12]; Sun and Allis, [@B81]; Lee et al., [@B43]). H3K27 demethylase UTX was shown to suppress the recruitment of PRC1 and subsequent H2A monoubiquitination (Lee et al., [@B44]). It was also shown that H2A monoubiquitination is coupled to H3K36me2 demethylation (Lagarou et al., [@B41]). These findings indicate that precise transcriptional control requires the concerted actions of multiple histone modifications.

DNA damage response
-------------------

Current studies suggest that histone ubiquitination is a general histone modification induced by DNA damage and plays important roles in DNA damage response. DNA damage has emerged as a major culprit in cancer and many other diseases. Inherited impairments in DNA repair usually leads to a higher risk of cancer. Cells developed a defense system against DNA damage, called DNA damage response, which includes recruitment of DNA repair machinery, cell cycle arrest, and lesion tolerance or apoptosis (Hoeijmakers, [@B25]).

One of the classic models to trigger DNA damage response is to introduce DNA double-strand break (DSB). Following DSBs, the histone variant H2AX is rapidly phosphorylated at the γ position (γH2AX) along chromatin tracks flanking DSBs by ATM, ATR, and DNA-PK (Falck et al., [@B14]). H2AX phosphorylation facilitates the accumulation of DNA damage response regulators, Mdc1/NFBD1(Stewart et al., [@B78]; Xu and Stern, [@B97]), RNF8 and RNF168. RNF8 and RNF168 catalyze the K63-linked polyubiquitination chain formation on histone H2A and H2AX (Huen et al., [@B26]; Kolas et al., [@B40]; Mailand et al., [@B52]; Stewart et al., [@B77]). K63-linked polyubiquitinated histones provide a recognition element that recruits RAP80 through its ubiquitin interaction motif (Kim et al., [@B35]; Sobhian et al., [@B76]; Wang et al., [@B85]). The subsequent recruitment of BRCA1 and the intact IR induced G2/M checkpoint are dependent on RAP80 and its ubiquitin binding motif that recognizes K63-linked polyubiquitin chains on H2A and H2AX (Kim et al., [@B35]; Sobhian et al., [@B76]; Wang and Elledge, [@B84]; Wang et al., [@B85]). Consistent with these findings, knockdown of histone ubiquitination enzymes impairs DSB-associated polyubiquitination of H2A and H2AX, inhibits retention of 53BP1 and BRCA1 at the DSB sites, and sensitizes cells to ionizing radiation (Huen et al., [@B26]; Kolas et al., [@B40]; Mailand et al., [@B52]; Stewart et al., [@B77]).

In addition to polyubiquitination, monoubiquitination of histones H2A, H2B, and H2AX also occurs at the sites of DNA damage. RING1B/BMI1 and RNF20/RNF40 are recruited to DSB site and catalyze H2A/H2AX monoubiquitination at lysine 119 and H2B monoubiquitination at lysine 120, respectively (Bergink et al., [@B1]; Marteijn et al., [@B54]; Wu et al., [@B93], [@B92]; Ginjala et al., [@B19]; Moyal et al., [@B58]; Pan et al., [@B63]). Furthermore, depletion of RNF20 or interference with histone H2B monoubiquitination disrupts the recruitment of DNA repair machine proteins in both non-homologous end joining (NHEJ) and homologous recombination repair (HRR) pathways to the DSB (Moyal et al., [@B58]). Histone DUBs, such as USP3 and K63-ub DUB BRCC36, are also critical for efficient DNA repair, suggesting that a dynamic regulation of histone ubiquitination and deubiquitination is required for DNA damage response (Shao et al., [@B73]). It was proposed that monoubiquitination of histones H2A and H2B interferes with chromatin compaction and therefore facilitates assembly of the repair machinery on the DNA damage foci (Moyal et al., [@B58]), but the mechanisms of action remain elusive.

Other functions
---------------

H2A monoubiquitination occurs on the inactive X chromosome in female mammals (de Napoles et al., [@B10]; Fang et al., [@B15]). Both RING1B and H2Aub are involved in the initiation of imprinted and random X chromosome inactivation (de Napoles et al., [@B10]; Fang et al., [@B15]).

In addition to transcription regulation, monoubiquitinated H2B is required for chromatin function in other ways. H2Bub is required for chromatin boundary integrity, and loss of H2Bub leads to the spreading of other histone modifications (Ma et al., [@B51]). The present of H2Bub also interferes with chromatin compaction and results in an open chromatin structure (Fierz et al., [@B16]). H2Bub is also shown to play an important role in homologous recombination through chromatin remodeling by recruiting chromatin remodeling factors. Cells lacking RNF20 or expressing H2B K120R, which lacks ubiquitin conjugation site, exhibit defects in HRR (Nakamura et al., [@B60]).

Histone ubiquitination and deubiquitination play essential roles in stem cell maintenance and differentiation, likely through controlling the expression of key pluripotency and differentiation genes. BMI1 is required for the self-renewal and maintenance of hematopoietic stem cells (Lessard and Sauvageau, [@B45]; Park et al., [@B64]) and neural stem cells (Molofsky et al., [@B57]). In flies, H2B DUB SCNY is required for the maintenance of germline stem cells, follicle stem cells, and intestinal stem cells. SCNY mutant animals display reduced number and half-life of germline stem cells (Buszczak et al., [@B4]). In mouse embryonic stem cells, ubiquitinated H2A restrains poised RNA polymerase II at a subset of developmental regulator genes. Loss of RING1A and RING1B releases poised RNA polymerase II and subsequent gene de-repression (Stock et al., [@B79]).

Furthermore, a recent landmark paper showed that H2Bub can function in trans independent of transcription (Latham et al., [@B42]). During mitosis, H2Bub is required for the kinetochore protein Dam1 methylation (Latham et al., [@B42]). Depletion of E2, E3 for H2B monoubiquitination or mutation of Lys-123 in H2B inhibits methylation of Dam1 (Latham et al., [@B42]). These results suggest that H2Bub also plays important roles outside of chromatin and is required for chromosome segregation.

Histone Ubiquitination and Cancer
=================================

Histone modifications play critical roles in genes expression and DNA repair. Aberrations of these processes often cause cancers (Jones and Baylin, [@B30]). Many histone modifying enzymes have been identified as oncogene or tumor suppressors (Chandrasekharappa et al., [@B6]; Yokoyama et al., [@B99]; Wissmann et al., [@B90]; Lin et al., [@B47]). Therefore, it is not a surprise that more and more connections between histone ubiquitination and cancer have been discovered. Monoubiquitinated histone H2A and H2B were found to be dramatically down-regulated in prostate and breast tumors, respectively (Zhu et al., [@B105]; Prenzel et al., [@B67]). Recently advances have also linked the writers, erasers, and readers of histone ubiquitination to tumorigenesis.

BRCA1
-----

Inactivation of tumor suppressor BRCA1 leads to breast and ovarian cancer. Female individuals carrying a mutated *BRCA1* allele have an estimated risk of 87% for breast cancer and 44% for ovarian cancer by age 70 (Ford et al., [@B17]). BRCA1 associated protein BAP1 is also a tumor suppressor in multiple cancers, including lung cancer, breast cancer, uveal melanoma, and mesothelioma (Harbour et al., [@B23]; Testa et al., [@B82]; Wiesner et al., [@B89]).

The BRCA1 protein is a RING finger domain containing E3 ubiquitin ligase. H2A and H2B were identified as BRCA1 substrates in an *in vitro* assay (Chen et al., [@B7]; Mallery et al., [@B53]). A more recently report showed that BRCA1 binds to satellite DNA regions and catalyzes monoubiquitination of H2A *in vivo* (Zhu et al., [@B106]). Loss of BRCA1 is associated with loss of H2A ubiquitination at satellite repeats and de-repression of satellite transcription. Cells lacking BRCA1 are impaired in organization of heterochromatin structure. More interestingly, ectopic expression of H2A fused to ubiquitin, which is a mimic of natural monoubiquitinated H2A, rescues BRCA1 phenotypes (Zhu et al., [@B106]). These findings indicate that BRCA1 maintains heterochromatin structure via monoubiquitination of H2A. Furthermore, the fact that satellite DNA transcripts are increased in BRCA1 mutant breast cancer samples, and the relationship between monoubiquitination of H2A and satellite DNA repression suggest that dysregulation of H2Aub plays important roles in tumorigenesis.

RNF20 and RNF40
---------------

RNF20 is the major H2B specific E3 ubiquitin ligase in mammalian cells. Besides a significant decrease in the cellular pool of monoubiquitinated H2B, RNF20 depletion causes increased expression of some proto-oncogenes and growth-related genes including c-myc and c-Fos (Shema et al., [@B75]). Further study discovered that RNF20 represses gene expression by disrupting the interaction between TFIIS and PAF1 elongation complex and inhibiting transcriptional elongation. Those effects are also dependent on the E3 ligase activity of RNF20 (Shema et al., [@B74]). In addition, RNF20 depleted cells showed decreased expression of the p53 tumor suppressor, and increased cell migration and tumorigenesis. Moreover, hypermethylation of RNF20 promoter was observed in tumor samples (Shema et al., [@B75]). These findings suggest that H2B ubiquitin ligase RNF20 is a putative tumor suppressor. Furthermore, the RNF40, a binding partner of RNF20 and another major E3 for H2B monoubiquitination also showed tumor suppressive activity in breast cancer cells (Prenzel et al., [@B67]).

USP22
-----

USP22 is a ubiquitin hydrolase and catalyzes the removal of ubiquitin from monoubiquitinated histones H2A and H2B (Zhang et al., [@B100], [@B101]; Zhao et al., [@B102]). USP22 is a putative cancer stem cell marker and was found to be highly expressed in malignant tumor samples. High level of USP22 in tumor tissues is associated with poor clinical outcome, including high risk of recurrence, metastasis, and resistance to chemotherapy (Glinsky, [@B20]; Glinsky et al., [@B21]; Zhang et al., [@B101]). Further studies determined that USP22 is recruited to the gene promoters by Myc and is required for the activation of Myc target genes (Zhang et al., [@B100]). Depletion of USP22 compromises Myc functions, including transformation. USP22 also play roles in cell cycle regulation, where depletion of USP22 increases the expression of p53 and p21, inhibits proliferation, and induces cell cycle arrest at G1 phase (Zhang et al., [@B100]; Lv et al., [@B50]).

Conclusion
==========

It is now well established that histone modifications and enzymes catalyzing their addition or removal are essential for normal cellular functions. Rapid advances of this field revealed that fine tuning of histone ubiquitination and deubiquitination is required for gene expression, DNA repair, and many other biological processes. Therefore aberrations of histone ubiquitination or deubiquitination lead to multiple human diseases including cancer. However, the precise mechanisms by which histone ubiquitination contributes to these biological processes are still poorly understood and require further investigation. Related essential questions include the crosstalk between histone ubiquitination and DNA methylation or other chromatin marks. Future studies that help decipher the essential roles of epigenetic regulation by histone ubiquitination in cellular homeostasis and pathological conditions like cancer will definitely benefit the identification of "druggable" targets for personalized cancer therapies.
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